Process Validation for Biopharmaceuticals 2012

The industry is moving towards a risk-based, lifecycle approach to process and analytical validation that will ensure continuous monitoring of the product pre and post-approval. IBC's Process and Product Validation conference will look at the industry's interpretation and implementation of FDA's new Process Validation Guidance, and will discuss how companies can successful integrate the new guidance into their existing validation programs.